Top Story

Prof. Ken Herrmann, director of the Department of Nuclear Medicine at University Hospital Essen, pictured fourth from the left, at the opening opening of a new nuclear medicine center in Essen, Germany, focused on theranostics and personalized cancer care.
Nuclear Medicine
Q&A with Ken Herrmann: Theranostics must move earlier and beyond established targets
Prof. Ken Herrmann discusses the expansion of radioligand therapy into earlier treatment lines, the need for new cancer targets, long-term safety, and the challenge of translating innovation into robust clinical evidence.
Featured
Example of AI-assisted pulmonary nodule detection and longitudinal volumetric assessment in a 65-year-old woman with peripheral arterial disease, a 24-pack-year smoking history, emphysema, and a family history of lung cancer. An incidental 8.5-mm right lower lobe pulmonary nodule is identified at CT angiography of the abdomen in July 2022 but does not receive follow-up. Subsequent imaging demonstrates interval growth, and CT-guided biopsy confirms stage IA lung adenocarcinoma. Contrast-enhanced axial chest CT images obtained on February 2, 2024, before robotic-assisted thoracoscopic segmentectomy, show a 12.1-mm spiculated right lower lobe pulmonary nodule. (A) Conventional contrast-enhanced axial chest CT image without AI assistance shows a 12.1-mm spiculated right lower lobe pulmonary nodule. (B) Corresponding CT image with AI-assisted pulmonary nodule detection, automated segmentation, and quantitative nodule assessment identifies a solid pulmonary nodule (nodule #1) measuring 13 × 8 (11) mm, with a volume of 739 mm3, a 45% volumetric increase compared with the previous contrast-enhanced chest CT performed on October 9, 2023 (510 mm3), and an estimated volume doubling time (VDT) of 216 days. (C) AI-generated longitudinal nodule analysis displays automated segmentation of the current (February 2, 2024) and previous (October 9, 2023) CT examinations, 3D nodule reconstruction, and quantitative volumetric assessment for longitudinal follow-up. The AI interface is displayed in the original software language (Dutch).
CT
AI cuts chest CT reporting time
Ken Herrman1
Nuclear Medicine
Video: Ken Herrmann maps nuclear medicine’s next frontiers
Latest News
This figure shows fused I-124 evuzamitide positron emission tomography (PET)/computed tomography (CT) images from patients without amyloidosis and from patients with ATTR cardiac amyloidosis, early ATTR cardiac amyloidosis, light chain cardiac amyloidosis, gelsolin-mediated amyloidosis, and systemic organ amyloid. The columns represent radiological transaxial, sagittal, and coronal views except for the last row middle and far right columns, which are coronal projections. The blue asterisks represent physiological activity (tracer activity in the stomach and esophagus). The arrowheads represent pathological uptake. Note the small amount of cardiac uptake in the basal septum and the basal lateral walls (likely early ATTR cardiac amyloidosis), splenic uptake and pleural uptake in light chain amyloidosis, and cardiac and kidney uptake in gelsolin-mediated amyloidosis. The bright yellow color represents more tracer uptake.
Bayer's PET agent meets endpoints in phase III cardiac amyloidosis study
August 31, 2026
Shutterstock 2437656775
SPECT, PET refine contemporary cardiac amyloidosis assessment
August 24, 2026
Examples of ultrasound findings and techniques. (A) Images in a 39-year-old male patient with a mass in the left thigh. The mass is heterogeneous on the B-mode US image (compared with the patient in D) and showed increased microvascularity (superb microvascular imaging [SMI]) and shear-wave elastography (SWE) values. Undifferentiated pleomorphic sarcoma was diagnosed at biopsy (with pleomorphic rhabdomyosarcoma in surgical specimen). (B) Images in an 18-year-old male patient with a mass in the left leg. The mass is hypoechoic on the B-mode image, with no other findings suggestive of malignancy. The lesion is in contact with the cortex of the tibia, which is slightly irregular. CT revealed a doubtful anteromedial tibial erosion. The microvascular study demonstrated high vascularization, suggestive of malignancy. Periosteal Ewing sarcoma was diagnosed with both histologic and immunohistochemical confirmation. (C) Images in a 69-year-old female patient with a lump growing on the outside of the left leg. Multiple SWE examinations were performed (please note the high values obtained in the measurements, whereas the color map highlights the stiffness relative to adjacent tissues). SMI showed areas of increased vascularization to target for sampling. Undifferentiated spindle cell sarcoma was diagnosed at biopsy, with residual leiomyosarcoma in the surgical specimen after neoadjuvant therapy. (D) Images in a 56-year-old female patient with a mass in the right thigh. The mass is heterogeneous at both B-mode ultrasound (similar to patient A) and MRI (coronal T2-weighted spectral attenuated inversion recovery [SPAIR]; T1-weighted pre-contrast and postcontrast imaging), which even shows uptake after the administration of paramagnetic contrast material, which is traditionally suggestive of malignancy. Low values at SMI and elastography are suggestive of benignity. Spindle cell lipoma was diagnosed at biopsy, with atypical spindle cell lipomatous tumor in the surgical specimen.
Advanced ultrasound techniques improve soft tissue tumor evaluation
August 26, 2026
Antoine Leimgruber
Swiss nuclear medicine seeks rules fit for radiopharmaceutical innovation
August 27, 2026
Cases of the Week
Check out our Cases of the Week!
Patient with abdominal pain revisited
A patient with abdominal pain out of proportion to the exam.
39-year-old man with chronic abdominal pain revisited
83-year-old female former smoker with imaging follow-up revisited
View All Cases
Prof. Ken Herrmann, director of the Department of Nuclear Medicine at University Hospital Essen, pictured fourth from the left, at the opening opening of a new nuclear medicine center in Essen, Germany, focused on theranostics and personalized cancer care.
Nuclear Medicine
Q&A with Ken Herrmann: Theranostics must move earlier and beyond established targets
CT
AI cuts chest CT reporting time
Molecular Imaging
Bayer's PET agent meets endpoints in phase III cardiac amyloidosis study
Nuclear Medicine
Video: Ken Herrmann maps nuclear medicine’s next frontiers
Nuclear Medicine
SPECT, PET refine contemporary cardiac amyloidosis assessment
Low-quality axial T2-weighted MRI scans with gradient-weighted class activation mapping. The low-quality MRI scans (top row) show blurred structures and artifacts making zonal and capsule boundaries indistinguishable. On the same scans with gradient-weighted class activation map overlays (bottom row), red indicates regions that were most heavily weighted by the deep learning model toward the low-quality prediction.
MRI
AI framework could improve MRI quality control in prostate cancer
AI
Review highlights opportunities and risks of AI in pediatric imaging
Womens Imaging
AI performs well in breast screening, but density complicates the picture
AI
EU AI Act brings radiology AI oversight into daily practice
AI
Radiologists can identify three out of four AI-generated images
Bir Full Colour
Molecular Imaging
BIR signs three-year collaboration agreement with IAEA
CT
GEHC's Photonova Spectra photon-counting CT receives CE Mark
Industry News
GEHC adds three systems to Vivid ultrasound portfolio
Industry News
Nanox AI signs distribution deal for HealthOST software
Industry News
Radiology Partners to acquire Everlight Radiology in $1 billion deal
More from AuntMinnieEurope
BIR signs three-year collaboration agreement with IAEA
By AuntMinnieEurope.com staff writers
The agreement aims to boost cooperation in radiology, nuclear medicine, medical physics, and radiation oncology.
September 1, 2026
Bir Full Colour
GEHC's Photonova Spectra photon-counting CT receives CE Mark
By AuntMinnie.com staff writers
The regulatory milestone follows U.S. Food and Drug Administration (FDA) 510(k) clearance in March.
August 31, 2026
GE HealthCare's Photonova Spectra photon-counting CT system.
GEHC adds three systems to Vivid ultrasound portfolio
By AuntMinnie.com staff writers
The company will showcase the ultrasound systems at the European Society of Cardiology (ESC) Congress 2026 in Munich.
August 28, 2026
From left to right: Vivid Explorer, Vivid Advanced, and Vivid Focus
Nanox AI signs distribution deal for HealthOST software
By AuntMinnie.com staff writers
The distribution deal with Vertec Scientific covers an initial three-year term.
August 27, 2026
Business Handshake 400
Radiology Partners to acquire Everlight Radiology in $1 billion deal
By AuntMinnie.com staff writers
Radiology Partners said it intends to make its Mosaic Drafting AI tool available to Everlight radiologists.
August 25, 2026
Acquisitions
Philips, Imricor launch MRI-guided cardiac intervention lab platform
By AuntMinnie.com staff writers
The platform combines Philips' 1.5T MRI system with Imricor's MR-compatible systems for MR-guided cardiac ablation.
August 27, 2026
Philips Rsna 2021 400
Leimgruber: Nuclear medicine needs regulation fit for innovation
By Claudia Tschabuschnig
In a video interview, Dr. Antoine Leimgruber, director ofdevelopment for nuclear medicine at Swiss Medical Network in Genolier, Switzerland, explores what is already changing in nuclear medicine and what continues to hold the specialty back.
August 26, 2026
Laim
Suhny Abbara talks AI in scientific publishing
By Claudia Tschabuschnig
Radiology editor-in-chief Dr. Suhny Abbara discusses the need for proactive AI guidance and what excites him most about leading the journal.
August 25, 2026
Suhny
Radiotherapy access could address gynecological cancer disparities
By Amerigo Allegretto
Inadequate radiotherapy infrastructure is one of several drivers of gynecological cancer disparities in LMICs.
August 24, 2026
Radiotherapy 400
How much surveillance imaging is needed for meningiomas?
By Amerigo Allegretto
Most surveillance MRI or CT exams did not result in intervention, and treatment rates remained stable during the study period.
August 21, 2026
Mri Slide 400
The retiring radiologist
By Paul McCoubrie, MBBS
In a new column, Dr. Paul McCoubrie reflects on aging and the prospect of retirement.
August 21, 2026
Dr. Paul McCoubrie
Review charts path toward standardized chest x-ray optimization
By Claudia Tschabuschnig
A 29-study review found no consensus on optimal beam quality for adult chest radiography, prompting calls for standardized research and safer, more consistent protocols.
August 19, 2026
Shutterstock 2474798495